The present invention relates to pharmaceutical compositions to be used in a solid galenic form for oral administration and primarily including dronedarone and/or at least one of the derivatives thereof as well as to solid galenic forms manufactured as such from said compositions preferably in the form of tablets or capsules. The present invention also relates to a method for preparing such solid galenic forms using a hot melt process.